Pulmonary hypertension in COPD and interstitial lung diseases

被引：3
|
作者：
Markart, P. [1 ,2 ]
Ghofrani, H. A. [1 ,2 ]
Grimminger, F. [1 ,2 ]
Guenther, A. [1 ,2 ]
机构：
[1] Univ Giessen Klinikum, Zentrum Innere Med, Med Klin & Poliklin 2, D-35392 Giessen, Germany
[2] Univ Klinikum Marburg, Zentrum Innere Med, Med Klin & Poliklin 2, D-35392 Giessen, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2009年 / 134卷
关键词：
pulmonary hypertension; chronic obstructive pulmonary disease; interstitial lung disease; vascular remodeling; TERM OXYGEN-THERAPY; CONTROLLED-TRIAL; EXERCISE CAPACITY; FIBROSIS; SILDENAFIL; SARCOIDOSIS; BOSENTAN;
D O I：
10.1055/s-0029-1225315
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S164 / S166
页数：3
相关论文
共 50 条
  • [31] Hospital Outcomes Among Patients Admitted with Pulmonary Hypertension Due to Interstitial Lung Diseases
    Chaparro, S.
    Rubens, M.
    Roy, M.
    Saxena, A.
    Vaidean, G.
    Jimenez, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S315 - S316
  • [32] Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
    Bongiovanni, Gabriele
    Tonutti, Antonio
    Stainer, Anna
    Nigro, Mattia
    Kellogg III, Dean L.
    Nambiar, Anoop
    Gramegna, Andrea
    Mantero, Marco
    Voza, Antonio
    Blasi, Francesco
    Aliberti, Stefano
    Amati, Francesco
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [33] Role of some neurohumoral factors in development of pulmonary hypertension in patients with interstitial lung diseases
    Arkhipova, DV
    Kornev, BM
    Popova, EN
    Kogan, EA
    Osipenko, VI
    Privalova, EV
    Kobylensky, AG
    Mescheryakova, SA
    Efremov, EE
    TERAPEVTICHESKII ARKHIV, 2003, 75 (03) : 44 - 49
  • [34] Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases Impact of Interstitial Lung Disease
    Mathai, Stephen C.
    Hummers, Laura K.
    Champion, Hunter C.
    Wigley, Fredrick M.
    Zaiman, Ari
    Hassoun, Paul M.
    Girgis, Reda E.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (02): : 569 - 577
  • [35] Pulmonary hypertension secondary to interstitial lung disease
    Shlobin, Oksana A.
    Nathan, Steven D.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 179 - 189
  • [36] THE ANALYSIS OF INTERSTITIAL LUNG DISEASE WITH PULMONARY HYPERTENSION
    Shen, N.
    RESPIROLOGY, 2011, 16 : 324 - 324
  • [37] Exercise Pulmonary Hypertension in Interstitial Lung Disease
    Henry, K. J.
    Gargani, L.
    Sultan, S.
    Saggar, R.
    Bossone, E.
    Saggar, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [38] Pulmonary hypertension in patients with interstitial lung disease
    Karampitsakos, Theodoros
    Tzouvelekis, Argyrios
    Chrysikos, Serafeim
    Bouros, Demosthenes
    Tsangaris, Iraklis
    Fares, Wassim H.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 50 : 38 - 46
  • [39] Pulmonary hypertension due to interstitial lung disease
    King, Christopher S.
    Nathan, Steven D.
    CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (05) : 459 - 467
  • [40] Value of pulmonary rehabilitation in interstitial lung diseases
    Elganady, Anwar Ahmed
    El Hoshy, Mona Saeed
    Eshmawey, Heba Ahmed
    Mohamed, Marwa Mokhtar
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (03): : 542 - 548
12345